International clinical trials setting for rare cancers: organisational and regulatory constraints—the EORTC perspective

Yazar: Shash, Emad, Negrouk, Anastassia, Marreaud, Sandrine, Golfinopoulos, Vassilis, Lacombe, Denis, Meunier, Francoise
Baskı/Yayın Bilgisi 2013

Survival of soft tissue sarcoma patients after completing six cycles of first-line anthracycline containing treatment: an EORTC-STBSG database study

Yazar: Verschoor, Arie Jan, Litière, Saskia, Marréaud, Sandrine, Judson, Ian, Toulmonde, Maud, Wardelmann, Eva, LeCesne, Axel, Gelderblom, Hans
Yayımlandı Clin Sarcoma Res (2020)

Long-term responders and survivors on pazopanib for advanced soft tissue sarcomas: subanalysis of two European Organisation for Research and Treatment of Cancer (EORTC) clinical tr...

Yazar: Kasper, B., Sleijfer, S., Litière, S., Marreaud, S., Verweij, J., Hodge, R. A., Bauer, S., Kerst, J. M., van der Graaf, W. T. A.
Yayımlandı Ann Oncol (2014)

Cytokine and angiogenic factors associated with efficacy and toxicity of pazopanib in advanced soft-tissue sarcoma: an EORTC-STBSG study

Yazar: Sleijfer, S, Gorlia, T, Lamers, C, Burger, H, Blay, J-Y, Le Cesne, A, Scurr, M, Collin, F, Pandite, L, Marreaud, S, Hohenberger, P
Baskı/Yayın Bilgisi 2012

Randomized Phase II/III Trial Assessing Gemcitabine/ Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer “Unfit” for Cisplatin-Based Ch...

Yazar: De Santis, Maria, Bellmunt, Joaquim, Mead, Graham, Kerst, J. Martijn, Leahy, Michael, Maroto, Pablo, Skoneczna, Iwona, Marreaud, Sandrine, de Wit, Ronald, Sylvester, Richard
Baskı/Yayın Bilgisi 2009

A randomized phase III study comparing standard dose BEP with sequential high-dose cisplatin, etoposide, and ifosfamide (VIP) plus stem-cell support in males with poor-prognosis ge...

Yazar: Daugaard, G., Skoneczna, I., Aass, N., De Wit, R., De Santis, M., Dumez, H., Marreaud, S., Collette, L., Lluch, J. R. G., Bokemeyer, C., Schmoll, H. J.
Baskı/Yayın Bilgisi 2011

Performance status is the most powerful risk factor for early death among patients with advanced soft tissue sarcoma The European Organisation for Research and Treatment of Cancer...

Yazar: Penel, N, Glabbeke, M V, Mathoulin-Pelissier, S, Judson, I, Sleijfer, S, Bui, B, Schoffski, P, Ouali, M, Marreaud, S, Brouste, V, Duhamel, A, Hohenberger, P, Blay, J-Y
Baskı/Yayın Bilgisi 2011

Retrospective quality control review of FDG scans in the imaging sub-study of PALETTE EORTC 62072/VEG110727: a randomized, double-blind, placebo-controlled phase III trial

Yazar: Hristova, Ivalina, Boellaard, Ronald, Vogel, Wouter, Mottaghy, Felix, Marreaud, Sandrine, Collette, Sandra, Schöffski, Patrick, Sanfilippo, Roberta, Dewji, Raz, van der Graaf, Winette, Oyen, Wim J. G.
Yayımlandı Eur J Nucl Med Mol Imaging (2015)

Outcomes of Elderly Patients with Advanced Soft Tissue Sarcoma Treated with First‐Line Chemotherapy: A Pooled Analysis of 12 EORTC Soft Tissue and Bone Sarcoma Group Trials

Yazar: Younger, Eugenie, Litière, Saskia, Le Cesne, Axel, Mir, Olivier, Gelderblom, Hans, Italiano, Antoine, Marreaud, Sandrine, Jones, Robin Lewis, Gronchi, Alessandro, van der Graaf, Winette T.A.
Yayımlandı Oncologist (2018)

Pazopanib in advanced desmoplastic small round cell tumours: a multi-institutional experience

Yazar: Frezza, Anna Maria, Benson, Charlotte, Judson, Ian R, Litiere, Saskia, Marreaud, Sandrine, Sleijfer, Stefan, Blay, Jean-Yves, Dewji, Raz, Fisher, Cyril, van der Graaf, Winette, Hayward, Larry
Baskı/Yayın Bilgisi 2014

Randomized Phase III Study Comparing Paclitaxel–Bleomycin, Etoposide, and Cisplatin (BEP) to Standard BEP in Intermediate-Prognosis Germ-Cell Cancer: Intergroup Study EORTC 30983

Yazar: de Wit, Ronald, Skoneczna, Iwona, Daugaard, Gedske, De Santis, Maria, Garin, August, Aass, Nina, Witjes, Alfred J., Albers, Peter, White, Jeffery D., Germa-Lluch, José R., Marreaud, Sandrine, Collette, Laurence
Baskı/Yayın Bilgisi 2012

Randomized Phase II/III Trial Assessing Gemcitabine/Carboplatin and Methotrexate/Carboplatin/Vinblastine in Patients With Advanced Urothelial Cancer Who Are Unfit for Cisplatin-Bas...

Yazar: De Santis, Maria, Bellmunt, Joaquim, Mead, Graham, Kerst, J. Martijn, Leahy, Michael, Maroto, Pablo, Gil, Thierry, Marreaud, Sandrine, Daugaard, Gedske, Skoneczna, Iwona, Collette, Sandra, Lorent, Julie, de Wit, Ronald, Sylvester, Richard
Baskı/Yayın Bilgisi 2012

EORTC-1203-GITCG - the “INNOVATION”-trial: Effect of chemotherapy alone versus chemotherapy plus trastuzumab, versus chemotherapy plus trastuzumab plus pertuzumab, in the periopera...

Yazar: Wagner, Anna Dorothea, Grabsch, Heike I., Mauer, Murielle, Marreaud, Sandrine, Caballero, Carmela, Thuss-Patience, Peter, Mueller, Lothar, Elme, Annelie, Moehler, Markus Hermann, Martens, Uwe, Kang, Yoon-Koo, Rha, Sun Young, Cats, Annemieke, Tokunaga, Masanori, Lordick, Florian
Yayımlandı BMC Cancer (2019)

Randomized Phase III Study Comparing Paclitaxel/Cisplatin/ Gemcitabine and Gemcitabine/Cisplatin in Patients With Locally Advanced or Metastatic Urothelial Cancer Without Prior Sys...

Yazar: Bellmunt, Joaquim, von der Maase, Hans, Mead, Graham M., Skoneczna, Iwona, De Santis, Maria, Daugaard, Gedske, Boehle, Andreas, Chevreau, Christine, Paz-Ares, Luis, Laufman, Leslie R., Winquist, Eric, Raghavan, Derek, Marreaud, Sandrine, Collette, Sandra, Sylvester, Richard, de Wit, Ronald
Baskı/Yayın Bilgisi 2012

Prognostic factors for soft tissue sarcoma patients with lung metastases only who are receiving first‐line chemotherapy: An exploratory, retrospective analysis of the European Orga...

Yazar: Lindner, Lars H., Litière, Saskia, Sleijfer, Stefan, Benson, Charlotte, Italiano, Antoine, Kasper, Bernd, Messiou, Christina, Gelderblom, Hans, Wardelmann, Eva, Le Cesne, Axel, Blay, Jean‐Yves, Marreaud, Sandrine, Hindi, Nadia, Desar, Ingrid M.E., Gronchi, Alessandro, van der Graaf, Winette T.A.
Yayımlandı Int J Cancer (2018)

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101...

Yazar: Schöffski, P, Wozniak, A, Stacchiotti, S, Rutkowski, P, Blay, J -Y, Lindner, L H, Strauss, S J, Anthoney, A, Duffaud, F, Richter, S, Grünwald, V, Leahy, M G, Reichardt, P, Sufliarsky, J, van der Graaf, W T, Sciot, R, Debiec-Rychter, M, van Cann, T, Marréaud, S, Lia, M, Raveloarivahy, T, Collette, L, Bauer, S
Yayımlandı Ann Oncol (2017)

Activity and safety of crizotinib in patients with advanced clear-cell sarcoma with MET alterations: European Organization for Research and Treatment of Cancer phase II trial 90101...

Yazar: Schöffski, P, Wozniak, A, Stacchiotti, S, Rutkowski, P, Blay, J -Y, Lindner, L H, Strauss, S J, Anthoney, A, Duffaud, F, Richter, S, Grünwald, V, Leahy, M G, Reichardt, P, Sufliarsky, J, van der Graaf, W T, Sciot, R, Debiec-Rychter, M, van Cann, T, Marréaud, S, Lia, M, Raveloarivahy, T, Collette, L, Bauer, S
Yayımlandı Ann Oncol (2019)

Comparison of Immediate vs Deferred Cytoreductive Nephrectomy in Patients With Synchronous Metastatic Renal Cell Carcinoma Receiving Sunitinib: The SURTIME Randomized Clinical Tria...

Yazar: Bex, Axel, Mulders, Peter, Jewett, Michael, Wagstaff, John, van Thienen, Johannes V., Blank, Christian U., van Velthoven, Roland, del Pilar Laguna, Maria, Wood, Lori, van Melick, Harm H. E., Aarts, Maureen J., Lattouf, J. B., Powles, Thomas, de Jong, MD, PhD, Igle Jan, Rottey, Sylvie, Tombal, Bertrand, Marreaud, Sandrine, Collette, Sandra, Collette, Laurence, Haanen, John
Yayımlandı JAMA Oncol (2018)

Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant Imatinib

Yazar: Gronchi, Alessandro, Bonvalot, Sylvie, Poveda Velasco, Andres, Kotasek, Dusan, Rutkowski, Piotr, Hohenberger, Peter, Fumagalli, Elena, Judson, Ian R., Italiano, Antoine, Gelderblom, Hans J., van Coevorden, Frits, Penel, Nicolas, Kopp, Hans-Georg, Duffaud, Florence, Goldstein, David, Broto, Javier Martin, Wardelmann, Eva, Marréaud, Sandrine, Smithers, Mark, Le Cesne, Axel, Zaffaroni, Facundo, Litière, Saskia, Blay, Jean-Yves, Casali, Paolo G.
Yayımlandı JAMA Surg (2020)

Association Between Immune-Related Adverse Events and Recurrence-Free Survival Among Patients With Stage III Melanoma Randomized to Receive Pembrolizumab or Placebo: A Secondary An...

Yazar: Eggermont, Alexander M. M., Kicinski, Michal, Blank, Christian U., Mandala, Mario, Long, Georgina V., Atkinson, Victoria, Dalle, Stéphane, Haydon, Andrew, Khattak, Adnan, Carlino, Matteo S., Sandhu, Shahneen, Larkin, James, Puig, Susana, Ascierto, Paolo A., Rutkowski, Piotr, Schadendorf, Dirk, Koornstra, Rutger, Hernandez-Aya, Leonel, Di Giacomo, Anna Maria, van den Eertwegh, Alfonsus J. M., Grob, Jean-Jacques, Gutzmer, Ralf, Jamal, Rahima, Lorigan, Paul C., Krepler, Clemens, Ibrahim, Nageatte, Marreaud, Sandrine, van Akkooi, Alexander, Robert, Caroline, Suciu, Stefan
Yayımlandı JAMA Oncol (2020)